Moorestown NJ, (October 14, 2019) – Tabula Rasa HealthCare (NASDAQ: TRHC) Vice President of Performance Improvement, Steven Gilbert, B.Sc. Pharmacy, MBA, BCPS, was named the 2019 recipient of the National Alliance of State Pharmacy Associations (NASPA) “Excellence in Innovation” Award. The award is given to a practicing New Jersey Pharmacists Association (NJPhA) member and pharmacist who has demonstrated innovative pharmacy practice resulting in improved patient care. The award was presented October 13, 2019 during the NJPhA 149th Annual Meeting and Awards Luncheon held at Harrah’s in Atlantic City, NJ.
“Steve has focused his extensive experience and knowledge in advancing health care in a fast-paced, innovative and technologically oriented environment at the level of individual patients, as well as capitulated populations, for over 40 years,” statesTRHC Chairman and CEO Calvin H. Knowlton. “He is one of the brightest pharmacists with whom I have worked in our 10 companies over the years. The remarkable attribute he possesses is intentional mentoring of pharmacists and student pharmacists, as well as guiding others around him to see their full potential and believe in themselves. Steve is clearly an innovator/developer/implementer in pharmacy.”
As Vice President of Performance Improvement for TRHC, a healthcare technology company advancing the field of medication safety, Gilbert leads the Company’s clinicians and analysts to influence prescribing patterns. This results in achieving patient-defined treatment goals while containing costs in both at-risk and fee-for-service environments, saving – on average – 10% of medication spend for new clients. Earlier in his career, Gilbert was Director of Pharmacy at Albert Einstein Healthcare Network in Philadelphia, PA and head of Professional Development for pharmacists at Hospice Pharmacia/excelleRx, a national medication management company for hospice patients overseeing more than 300 pharmacists.
Gilbert’s tangible achievements and successes include the development and implementation of an antibiotic streamlining program with Infectious Disease physicians that saved over $250K annually in medication (antibiotics) expenses; design and implementation of drug use evaluation programs that insured safety and appropriateness of high-risk medications; creation of innovative methods of providing pharmaceutical care via telephone and the Internet that leverage pharmacists’ clinical skills in end-of-life care planning for over 80,000 patients and more.
“Steve is passionate about the contributions pharmacists make in healthcare,” says TRHC President, Orsula V. Knowlton, PharmD. “He is committed to motivating individuals to practice at the top of their pharmacy license. He is a role model, patient advocate and pharmacist champion. Steve Gilbert is deserving of the recognition “Excellence in Innovation”. We, his colleagues at TRHC, could not be more proud of or pleased that he is receiving this prestigious award.”
Gilbert is a graduate of the Philadelphia College of Pharmacy and Sciences with meritorious honors, he completed a pharmacy residency at Thomas Jefferson University Hospital in and earned a MBA from St. Joseph’s University.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 1, 2019, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.